Xu, K., Gu, T., Su, K., Liu, X., He, B., He, J., . . . Han, Y. (2025). Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma. Discover. Oncology, 16(1), 1081-19. https://doi.org/10.1007/s12672-025-02914-4
Chicago-Zitierstil (17. Ausg.)Xu, Ke, et al. "Stereotactic Body Radiation Therapy (SBRT) Increases Anti-PD-1 Antitumor Activity by Enhancing the Tumor Immune Microenvironment in Mice with Metastatic Hepatocellular Carcinoma." Discover. Oncology 16, no. 1 (2025): 1081-19. https://doi.org/10.1007/s12672-025-02914-4.
MLA-Zitierstil (9. Ausg.)Xu, Ke, et al. "Stereotactic Body Radiation Therapy (SBRT) Increases Anti-PD-1 Antitumor Activity by Enhancing the Tumor Immune Microenvironment in Mice with Metastatic Hepatocellular Carcinoma." Discover. Oncology, vol. 16, no. 1, 2025, pp. 1081-19, https://doi.org/10.1007/s12672-025-02914-4.